BioHealth News Archive

MacroGenics to Develop Cancer Compound Worldwide as Servier Alliance Ends | GEN News Highlights | GEN

MacroGenics to Develop Cancer Compound Worldwide as Servier Alliance Ends | GEN News Highlights | GEN

MacroGenics said today it has regained full global rights to the Phase I cancer compound enoblituzumab (MGA271), after Servier opted not to exercise its…

Read More
Personal Genome Diagnostics lands $21.4M investment to expand cancer testing – Baltimore Sun

Personal Genome Diagnostics lands $21.4M investment to expand cancer testing – Baltimore Sun

Personal Genome Diagnostics, a Baltimore company that analyzes cancer patients' genes to improve treatment and diagnosis, has received a $21.4 million venture capital investment…

Read More
UMD and Johns Hopkins develop model to predict hospital bed count – The Diamondback

UMD and Johns Hopkins develop model to predict hospital bed count – The Diamondback

When the demand for hospital beds exceeds the supply, doctors might have to turn patients away. But a computer model developed by University of…

Read More
Relevant Health accelerator announces inaugural class – Technical.ly DC

Relevant Health accelerator announces inaugural class – Technical.ly DC

Relevant Health, a health-tech accelerator based in Rockville, announced and welcomed its inaugural cohort Tuesday. The seven selected startups will begin their five-month program this…

Read More
WIB-DC/Baltimore Presents “A Fresh Start Part II: Continuing your Career Development”

WIB-DC/Baltimore Presents “A Fresh Start Part II: Continuing your Career Development”

Are you planning your career path or currently transitioning between careers? If you attended last January’s webinar on “Career Development,” and would like to…

Read More
Why Hearables May Be The Next Big Thing In Tech – ReadWrite

Why Hearables May Be The Next Big Thing In Tech – ReadWrite

Recently, at the annual Dreamforce Conference in San Francisco, Microsoft CEO Satya Nadella declared a new era in computing defined by wearable devices. “People…

Read More
ClearPath Development Launches Second Vaccine Company Under Strategic Partnership With Astellas – FierceVaccines

ClearPath Development Launches Second Vaccine Company Under Strategic Partnership With Astellas – FierceVaccines

ClearPath Development Company (ClearPath) announced today the launch of its second vaccine company, NVC (Nosocomial Vaccine Corporation), with the support of its partner, Astellas…

Read More
Sisu Global Health Wins Mid-Atlantic Bio Angels 1st Pitch Life Science Competition – MarketWatch

Sisu Global Health Wins Mid-Atlantic Bio Angels 1st Pitch Life Science Competition – MarketWatch

Mid-Atlantic Bio Angels (MABA) announces today that Sisu Global Health (http://www.sisuglobalhealth.com) was voted as "Best in Show" at MABA's 1st Pitch Life Science event,…

Read More
Here’s a look at 1776’s new Crystal City incubator space (Video) – Washington Business Journal

Here’s a look at 1776’s new Crystal City incubator space (Video) – Washington Business Journal

D.C. tech accelerator 1776’s new Crystal City location is designed to be a mixture of old and new — everything from the reclaimed wooden…

Read More
NEA Promotes Sara Nayeem, M.D. To Partner

NEA Promotes Sara Nayeem, M.D. To Partner

Global venture capital firm New Enterprise Associates, Inc. (NEA) today announced the promotion of Sara Nayeem, M.D., to Partner. Dr. Nayeem joined NEA's healthcare…

Read More
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates

Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates

Personal Genome Diagnostics, Inc. (PGDx), a provider of advanced cancer genome testing products and services, today announced that it has raised $21.4 million in…

Read More
UM Baltimore Grants Glycocept Rights To A Technology Designed To Increase The Efficacy Of Therapeutic Monoclonal Antibodies | UM Ventures

UM Baltimore Grants Glycocept Rights To A Technology Designed To Increase The Efficacy Of Therapeutic Monoclonal Antibodies | UM Ventures

University of Maryland (UM) Ventures and Glycocept, Inc. announced today that the University of Maryland, Baltimore (UMB) has granted Glycocept worldwide, exclusive licensing rights…

Read More
Educational & Scientific, LLC And University Of Maryland, Baltimore Sign An Agreement To Develop And Commercialize Novel Treatment For Major Cancers | UM Ventures

Educational & Scientific, LLC And University Of Maryland, Baltimore Sign An Agreement To Develop And Commercialize Novel Treatment For Major Cancers | UM Ventures

University of Maryland (UM) Ventures and Educational and Scientific LLC (ESL), announced today that the University of Maryland, Baltimore (UMB) granted ESL exclusive licensing…

Read More
Northwest Biotherapeutics NW Bio Has Entered Into An Agreement For $30 Million Of New Equity Funding From Woodford Investment Management – Northwest Biotherapeutics

Northwest Biotherapeutics NW Bio Has Entered Into An Agreement For $30 Million Of New Equity Funding From Woodford Investment Management – Northwest Biotherapeutics

Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the Company…

Read More
Baltimore startup chosen for Rockville accelerator – Maryland Daily Record

Baltimore startup chosen for Rockville accelerator – Maryland Daily Record

Baltimore-based AgeWell Biometrics has been selected a member of the inaugural startup class with Relevant Health, a health technology startup accelerator in Rockville, officials…

Read More